TRV GP IV
Boston, MAfiles as TRV GP IV, LLC
$254m in 2 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 2.6% of the portfolio this quarter.
Value
$254m
Stocks
2
Top 10 share
100.0%
Turnover
2.6%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Maze TherapeuticsMAZE | 52.6% | $134m | 4,473,958 | Held |
| Tango TherapeuticsTNGX | 47.4% | $120m | 6,374,574 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 55.3% since 30 June 2025.
Where the money is
Health care100.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.